Company Quick10K Filing
Nutra Pharma
10-Q 2018-09-30 Filed 2018-11-19
10-Q 2018-06-30 Filed 2018-08-17
10-Q 2018-03-31 Filed 2018-05-21
10-K 2017-12-31 Filed 2018-04-17
10-Q 2017-09-30 Filed 2017-11-20
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-17
10-K 2016-12-31 Filed 2017-04-17
10-Q 2016-09-30 Filed 2016-11-22
10-Q 2016-06-30 Filed 2016-08-22
10-Q 2016-03-31 Filed 2016-05-27
10-K 2015-12-31 Filed 2016-04-14
10-Q 2015-09-30 Filed 2015-11-23
10-Q 2015-06-30 Filed 2015-08-18
10-Q 2015-03-31 Filed 2015-05-19
10-K 2014-12-31 Filed 2015-04-13
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-20
10-K 2013-12-31 Filed 2014-03-31
10-Q 2013-09-30 Filed 2013-11-19
10-Q 2013-06-30 Filed 2013-08-19
10-Q 2013-03-31 Filed 2013-05-20
10-K 2012-12-31 Filed 2013-04-16
10-Q 2012-09-30 Filed 2012-12-05
10-Q 2012-06-30 Filed 2012-12-03
10-Q 2012-03-31 Filed 2012-11-21
10-K 2011-12-31 Filed 2012-11-13
10-Q 2011-09-30 Filed 2011-11-15
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-16
10-K 2010-12-31 Filed 2011-04-01
10-Q 2010-09-30 Filed 2010-11-15
10-Q 2010-06-30 Filed 2010-08-16
10-Q 2010-03-31 Filed 2010-05-21
10-K 2009-12-31 Filed 2010-04-15
8-K 2018-10-03
8-K 2018-09-28
8-K 2018-02-23

Nutra Pharma Financials

NPHC Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Natcore Technology (NXT)
OncBioMune (OBMP) 0 0.0 -1,707% 413 14,090 0 0 -7,048 -5,617 -136
Cantabio Pharmaceuticals (CTBO) 0 0.9 -474% 326 2,215 0 0 -1,543 -331 -283
Amplitude Healthcare (AMHCU)
GIFA (FRFS) 0 63% -0.9 43% 80 362 98 62 34 34 -30
Highcom Global Security (HCGS) 0 41% -0.8 1% 9,334 1,222 4,918 2,033 57 172 -131
Nutra Pharma (NPHC) 0 71% -0.2 -2,939% 252 5,614 106 75 -7,398 -6,591 1,498
Premier Biomedical (BIEI) 0 58% -0.3 -183% 186 2,304 13 8 -340 -238 75
Electromedical Technologies (ELCQ)
DigitalTown (DGTW) 0 12,618% 0.0 -16,557% 34 2,761 -2 -220 -5,706 -5,268 -34
Life Clips (LCLP) 0 135% -0.7 -21,823% 16 9,270 -86 -116 -3,494 -3,182 2,355
Anchiano Therapeutics (ANCN)
X Rail Entertainment (XREE) 0 -0.1 -1,441,401% 0 3,429 0 0 -5,261 -5,732 345
Bulova Technologies (BTGI)
Angiosoma (SOAN) 0 64% -0.2 -475% 142 828 0 0 -675 -315 66
GH Capital (GHHC) 0 66% -0.0 -2,680% 89 331 211 139 -2,374 -2,374 59
Galileo Acquisition (GLEO)
Sunshine Biopharma (SBFM) 0 30% 0.1 -864% 146 889 130 38 -1,264 -1,160 -82
True Drinks Holdings (TRUU) 0 57% 1.7 -26% 9,780 7,642 12,437 7,052 -2,515 -2,482 -4,166
Triton Emission Solutions (DSOX) 0 0.0 -10,306% 20 18,837 0 0 -2,068 -831 -1

Balance Sheet ($'000)2011-06-302011-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Cash2726800265104428160119478203118622314
Accounts Receivable354588384417281119361621271371601172230383138364515161617
Inventory4007940555474847555452512624212020755942
PP&E52431811811811811812117201203204204204204204204207207207207216216216216
Assets1,0041,540303210153266129101216362387540604584388289346214197146137390476601252
Accounts Payable7438618018911,0399961,0191,1051,1901,2381,2441,3551,2721,3098429819399581,0281,1571,2521,3021,3801,4151,533
Long-Term Debt808809911,1441,4271,3331,5531,3481,3761,4231,9221,8221,4321,9261,6461,9211,513
Liabilities3,3753,9533,8794,0373,8644,8354,3494,0754,1803,9203,9824,0825,1375,5063,9624,4754,4514,6915,2385,3865,1805,8005,6395,7065,614
Stockholders' Equity-2,370-2,413-3,576-3,827-3,711-4,569-4,219-3,973-3,964-3,558-3,595-3,542-4,532-4,922-3,574-4,186-4,104-4,477-5,041-5,240-5,043-5,410-5,163-5,105-5,362
Income Statement ($'000)2011-06-302011-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Revenue2792523822392355114275166121785339317030173338322944
Cost of Revenue6288716611819503925201391110118114461737
Gross Profit21816331633124796225127965840312061-165922342927137
R&D61170
SG&A7667923623645771,1382757237479383891,0553,957591629567409427438307304364349861
Tax00000000000000000000
Net Income-598-662-473-609-2,647-614-2071,121-205-802-364-1,766-3,938676-654-644-1,075-940-1,115-981-992-4,088-1,350-968
Cash Flow ($'000)2011-06-302011-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Cash Operating-886-72-93-252-9122-22-57-117-502-208-190-419-388-371-296-245-226-348-353-163
Cash Investing00000-20-1-1000-20-9
Cash Financing88564932779612264710262194193433402359283239236350374154